Patents by Inventor Joseph J. CAMPO, Jr.

Joseph J. CAMPO, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS
    Publication number: 20220409713
    Abstract: Described herein are compositions that comprise one or more Babesia microti antigens, one or more Babesia microti nucleic acid molecules, or one or more anti-Babesia microti antibodies and uses thereof in methods for the prophylaxis of babesiosis, the treatment of babesiosis and the monitoring of individuals undergoing prophylactic or therapeutic administration of the compositions of the invention.
    Type: Application
    Filed: June 2, 2022
    Publication date: December 29, 2022
    Inventors: Edouard VANNIER, Joseph J. CAMPO, JR.
  • COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS
    Publication number: 20220395564
    Abstract: Described herein are compositions that comprise one or more Babesia microti antigens, one or more Babesia microti nucleic acid molecules, or one or more anti-Babesia microti antibodies and uses thereof in methods for the prophylaxis of babesiosis, the treatment of babesiosis and the monitoring of individuals undergoing prophylactic or therapeutic administration of the compositions of the invention.
    Type: Application
    Filed: November 25, 2020
    Publication date: December 15, 2022
    Inventors: Edouard VANNIER, Joseph J. CAMPO, JR.
  • Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines
    Patent number: 10197577
    Abstract: Disclosed herein are diagnostic methods and compositions for identifying individuals that are protected against Plasmodium falciparum caused malaria. Such methods are particularly useful for determining not only the protective efficacy of Pf whole parasite vaccines for individual subjects, but also within populations of vaccinated subjects. Also disclosed herein are subunit vaccines comprising at least one Pf immunologic determinant for protection against Plasmodium-caused malaria.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: February 5, 2019
    Assignees: Sanaria Inc., Antigen Discovery, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Philip Felgner, Stephen L. Hoffman, Robert Seder, Joseph J. Campo, Jr.
  • SERUM ANTIBODY ASSAY FOR DETERMINING PROTECTION FROM MALARIA, AND PRE-ERYTHROCYTIC SUBUNIT VACCINES
    Publication number: 20180231566
    Abstract: Disclosed herein are diagnostic methods and compositions for identifying individuals that are protected against Plasmodium falciparum caused malaria. Such methods are particularly useful for determining not only the protective efficacy of Pf whole parasite vaccines for individual subjects, but also within populations of vaccinated subjects. Also disclosed herein are subunit vaccines comprising at least one Pf immunologic determinant for protection against Plasmodium-caused malaria.
    Type: Application
    Filed: December 29, 2017
    Publication date: August 16, 2018
    Applicants: Sanaria Inc., Antigen Discovery, Inc., The United States of America, as represented by the Secretary, Department of Health and Human
    Inventors: Philip FELGNER, Stephen L. HOFFMAN, Robert SEDER, Joseph J. CAMPO, JR.
  • SERUM ANTIBODY ASSAY FOR DETERMINING PROTECTION FROM MALARIA, AND PRE-ERYTHROCYTIC SUBUNIT VACCINES
    Publication number: 20160320404
    Abstract: Disclosed herein are diagnostic methods and compositions for identifying individuals that are protected against Plasmodium falciparum caused malaria. Such methods are particularly useful for determining not only the protective efficacy of Pf whole parasite vaccines for individual subjects, but also within populations of vaccinated subjects. Also disclosed herein are subunit vaccines comprising at least one Pf immunologic determinant for protection against Plasmodium-caused malaria.
    Type: Application
    Filed: March 4, 2016
    Publication date: November 3, 2016
    Applicants: Sanaria Inc., Antigen Discovery, Inc., The United States of America, as represented by the Secretary, Department of Health and Human
    Inventors: Philip FELGNER, Stephen L. HOFFMAN, Robert SEDER, Joseph J. CAMPO, Jr.